Specificities were found to be 98.9% (range 93.9%– 100.0%) for the VectoCrimean-CHF-IgM tests and 100% (range 95.8%–100%) for the VectoCrimean-CHF-IgG test [3]. This evidence concerns the gene CD40LG and congestive heart failure.